Results 171 to 180 of about 5,379,499 (310)
Application of the Wigner distribution to monitoring cutting tool condition [PDF]
This thesis is about the application of the Wigner distribution to cutting tool monitoring and control. After reviewing traditional methods, a new method is proposed.
Zheng, Kougen
core
Refining MediQuit: an iterative, participatory approach to shared decision-making in deprescribing. [PDF]
Kornder N +4 more
europepmc +1 more source
Single‐cell multi‐omics reveals epigenetic heterogeneity across therapy‐adaptive tumor states, including quiescent/dormant, drug‐tolerant persister, and EMT‐like phenotypes. By linking regulatory features with state‐associated biomarkers, these approaches inform biomarker‐guided therapeutic strategies for evolving tumors.
Hee Jung Kim +3 more
wiley +1 more source
Impact of reader experience on the time-saving potential of a novel computer-aided tool for Ann Arbor staging of pediatric hodgkin lymphoma. [PDF]
Vasyliv I +10 more
europepmc +1 more source
Breast cancer remains a major cause of cancer death in women, frequently developing endocrine therapy resistance. This study demonstrates that upregulated p21‐activated kinase 1 (PAK1) activity drives resistance to tamoxifen and long‐term estrogen deprivation in ER+ breast cancer models.
Luisa Schwarzmüller +10 more
wiley +1 more source
The Effect of Material Microstructures on Tool Edge Preparation of PCBN Cutting Tools. [PDF]
Huang Z, Wu X, Zhang C, Zhai Y.
europepmc +1 more source
The proposed mechanism of action for the CDK12/13 inhibitor and cyclin K degrader, CT7439. CDK12/13 inhibition interrupts transcription elongation, leading to increased DNA damage that results in cell death. This agent is a potentially novel treatment option for patients with colorectal cancer. Created in BioRender. Cyclin‐dependent kinase (CDK) 12 and
Wylie K. Watlington +10 more
wiley +1 more source
Data collection tool for stakeholders’ mapping (AR)
This research tool is a stakeholder matrix based on pre-defined outreach queries aimed at performing the stakeholder mapping that will feed into the social network analysis.
Ouerghemmi, Hassen
core +1 more source
Preliminary feedback from adult oncology clinic providers on a psychosocial screening tool for young adult patients with cancer. [PDF]
Wrucke MW +5 more
europepmc +1 more source
Drug resistance limits treatment success in a subset of lung cancers driven by ROS1 gene alterations. Using patient‐derived cells and computer simulations, we studied three key mutations and how they affect five targeted drugs. The mutations reduced drug effectiveness in different ways by altering protein structure and behavior.
Farhan Ul Haq +8 more
wiley +1 more source

